171 related articles for article (PubMed ID: 19883279)
1. Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Ulukaya E; Yilmaz Y; Moshkovskii S; Karpova M; Pyatnitskiy M; Atug O; Dolar E
Scand J Gastroenterol; 2009; 44(12):1471-6. PubMed ID: 19883279
[TBL] [Abstract][Full Text] [Related]
2. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
3. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
5. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
6. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
[TBL] [Abstract][Full Text] [Related]
7. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
8. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
[TBL] [Abstract][Full Text] [Related]
10. Proteomics analysis of human nonalcoholic fatty liver.
Rodriguez-Suarez E; Mato JM; Elortza F
Methods Mol Biol; 2012; 909():241-58. PubMed ID: 22903720
[TBL] [Abstract][Full Text] [Related]
11. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
12. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
13. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.
Srinivasan R; Daniels J; Fusaro V; Lundqvist A; Killian JK; Geho D; Quezado M; Kleiner D; Rucker S; Espina V; Whiteley G; Liotta L; Petricoin E; Pittaluga S; Hitt B; Barrett AJ; Rosenblatt K; Childs RW
Exp Hematol; 2006 Jun; 34(6):796-801. PubMed ID: 16728285
[TBL] [Abstract][Full Text] [Related]
14. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
15. N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.
Blomme B; Francque S; Trépo E; Libbrecht L; Vanderschaeghe D; Verrijken A; Pattyn P; Nieuwenhove YV; Putte DV; Geerts A; Colle I; Delanghe J; Moreno C; Gaal LV; Callewaert N; Vlierberghe HV
Dig Liver Dis; 2012 Apr; 44(4):315-22. PubMed ID: 22119618
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers.
Shen J; Chan HL; Wong GL; Choi PC; Chan AW; Chan HY; Chim AM; Yeung DK; Chan FK; Woo J; Yu J; Chu WC; Wong VW
J Hepatol; 2012 Jun; 56(6):1363-70. PubMed ID: 22314419
[TBL] [Abstract][Full Text] [Related]
17. Validation of the non-alcoholic fatty liver disease activity score.
Hjelkrem M; Stauch C; Shaw J; Harrison SA
Aliment Pharmacol Ther; 2011 Jul; 34(2):214-8. PubMed ID: 21585409
[TBL] [Abstract][Full Text] [Related]
18. Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease.
Blomme B; Fitzpatrick E; Quaglia A; De Bruyne R; Dhawan A; Van Vlierberghe H
Pediatr Obes; 2012 Apr; 7(2):165-73. PubMed ID: 22434757
[TBL] [Abstract][Full Text] [Related]
19. Behcet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS.
Wang X; Zhang MF; Xie J; Li ZL; Wang P
Anat Rec (Hoboken); 2012 Jul; 295(7):1168-73. PubMed ID: 22641412
[TBL] [Abstract][Full Text] [Related]
20. Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry coupled with an artificial neural network model for the diagnosis of hepatocellular carcinoma.
Hu Q; Huang Y; Wang Z; Tao H; Liu J; Yan L; Wang K
Hepatogastroenterology; 2012 Sep; 59(118):1902-6. PubMed ID: 22193438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
